Company: HSDTW
Filing Date: 2025-09-15
Form Type: 424B5
Source: 0001104659-25-089776
Chunk: 13

Company: Solana Co
Filing Date: 2025-09-15
Form: 424B5
Chunk 13
---
; (ii) approved an amendment to the Company’s Certificate of Incorporation to increase the number of authorized shares of common stock to up to 800,000,000 shares; (iii) approved, pursuant to Nasdaq listing rules, the issuance of up to 148,621,326 shares of common stock in a potential financing; (iv) approved an amendment to the Helius Medical Technologies, Inc. 2022 Equity Incentive Plan to increase the number of shares available under the plan following this offering and the total dilution associated with this offering; and (v) approved authorization of one or more adjournments to the Special Meeting to solicit additional proxies in the event there were insufficient votes to approve any of the other proposals (collectively, the “Special Meeting Stockholder Approvals”). The Company intends to file an amendment to the Company’s Certificate of Incorporation to increase the number of authorized shares of common stock to up to 800,000,000 shares.

#### Reverse Stock Splits
On April 21, 2025, the stockholders of the Company approved a potential reverse stock split in a ratio of 1-to-2 to 1-to-250. The Board subsequently approved a reverse stock split of 1-for-15, which became effective on May 2, 2025.

On May 23, 2025, the stockholders of the Company approved a potential reverse stock split in a ratio of 1-to-2 to 1-to-30. The Board subsequently approved a reverse stock split of 1-for-50, which became effective on June 30, 2025. All numbers herein have been adjusted to reflect these reverse stock splits.

#### Private Placements
On April 24, 2025, the Company entered into a securities purchase agreement (the “PIPE Purchase Agreement”) with certain investors (the “Purchasers”) pursuant to which the Company sold, in a private placement (the “April 2025 Private Placement”), unsecured 20% original issue discount promissory notes with an aggregate principal amount of $1,560,000 (the “Notes”) with a maturity date of the earlier of (a) July 24, 2025, and (b) the closing date of the Company’s next registered offering of securities on Form S-1. The PIPE Purchase Agreement also provided for the issuance of an aggregate of 88,010 shares of common stock of the Company to the Purchasers. The transaction closed on April 25,